4.7 Review

Novel insights in endocrine and metabolic pathways in sepsis and gaps for future research

Journal

CLINICAL SCIENCE
Volume 136, Issue 11, Pages 861-878

Publisher

PORTLAND PRESS LTD
DOI: 10.1042/CS20211003

Keywords

-

Funding

  1. Research Foundation-Flanders (FWO) [G091918N]
  2. Methusalem Program of the Flemish Government [METH/14/06]
  3. European Research Council from European Union's Horizon 2020 research and innovation program [AdvG-2017-785809]
  4. European Respiratory Society (ERS Gold Medal in ARDS)
  5. University Hospitals Leuven

Ask authors/readers for more resources

Sepsis is a life-threatening organ dysfunction caused by a dysregulated response to infection. Preclinical and clinical research have shown that there is a biphasic pattern in the neuroendocrine responses to sepsis, contributing to the development of severe metabolic alterations. Early full feeding in the acute phase induced harm, while the benefits of metabolic alterations such as hyperglycemia are still unclear.
Sepsis is defined as any life-threatening organ dysfunction caused by a dysregulated host response to infection. It remains an important cause of critical illness and has considerable short- and long-term morbidity and mortality. In the last decades, preclinical and clinical research has revealed a biphasic pattern in the (neuro-)endocrine responses to sepsis as to other forms of critical illness, contributing to development of severe metabolic alterations. Immediately after the critical illness-inducing insult, fasting- and stress-induced neuroendocrine and cellular responses evoke a catabolic state in order to provide energy substrates for vital tissues, and to concomitantly activate cellular repair pathways while energy-consuming anabolism is postponed. Large randomized controlled trials have shown that providing early full feeding in this acute phase induced harm and reversed some of the neuro-endocrine alterations, which suggested that the acute fasting- and stress-induced responses to critical illness are likely interlinked and benefical. However, it remains unclear whether, in the context of accepting virtual fasting in the acute phase of illness, metabolic alterations such as hyperglycemia are harmful or beneficial. When patients enter a prolonged phase of critical illness, a central suppression of most neuroendocrine axes follows. Prolonged fasting and central neuroendocrine suppression may no longer be beneficial. Although pilot studies have suggested benefit of fasting-mimicking diets and interventions that reactivate the central neuroendocrine suppression selectively in the prolonged phase of illness, further study is needed to investigate patient-oriented outcomes in larger randomized trials.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available